NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/20/2024
Back to search
Official data from USPTO
LUMICISION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
02/20/2024
Trademark type
Combined
Nice classes
5
Filing date
06/01/2022
Registration date
02/20/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/20/2024
Last transaction
02/20/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
08/11/2022
First use in commerce
08/11/2022
Drawing code
3
Owner type
99
Owner location
Hangzhou City, CN
Examiner
REINHART, MEGHAN
Law office
L80
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "LUMICISION" with the "L" being capitalized and with two wavy lines appearing below the lettering "LUMICI".
Holders and representatives
Holders
Assure Tech (Hangzhou) Co., Ltd.
Representatives
Xionghui murong
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Chemical preparations for pharmaceutical or medical purposesfor Infectious disease and chronic disease detection; Chemical preparations for the diagnosis of pregnancy; Diagnostic agentspreparations and substances for medical purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for medical purposes for detecting the presence of malignantinflammatory and autoimmune disorders and conditions and tissue trauma in humans; Enzyme preparations for medical purposes; Immunoassay reagents for medical use; Reagent paper for medical purposes; Reagents for use in medical genetic testing
Publications
History of USPTO decisions and trademark events.
29 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/20/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/16/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/13/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/07/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/07/2024
IUAF
USE AMENDMENT FILED
12/18/2023
EISU
TEAS STATEMENT OF USE RECEIVED
12/18/2023
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
12/14/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/14/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/14/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/14/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/20/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/25/2023
PUBO
PUBLISHED FOR OPPOSITION
04/25/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/05/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/23/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
03/23/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/23/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
03/23/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/23/2023
DOCK
ASSIGNED TO EXAMINER
03/17/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/13/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
01/13/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/13/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/13/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/10/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/09/2022
NWAP
NEW APPLICATION ENTERED
06/04/2022
Continuous trademark protection
Get notified about every new filing that threatens LUMICISION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.